Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$18.18 USD
-0.23 (-1.25%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $18.16 -0.02 (-0.11%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SBRA 18.18 -0.23(-1.25%)
Will SBRA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SBRA
Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Q2 FFO and Revenues Surpass Estimates
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for SBRA
Sabra Health Care declares $0.30 dividend
Sabra projects $500M in 2025 investments as SHOP portfolio targets 30% run rate by 2026
Sabra Health Care REIT, Inc. (SBRA) Q2 2025 Earnings Call Transcript
Sabra Health Care REIT, Inc. 2025 Q2 - Results - Earnings Call Presentation
Sabra Health Care files automatic mixed securities shelf